Home - Biotech Today

After clearing out heart disease drug, Arrowhead maps out obesity development plans

Biotechnology Today November 21, 2024 By News Team
Denali reports new method to get antisense oligonucleotides across blood-brain barrier

Biotechnology Today November 21, 2024 By News Team
Medable launches Medable Studio, an all-in-one software solution

Biotechnology Today November 21, 2024 By News Team

Scientists discover free-floating bacterial gene that challenges cardinal rules of biology

Biotechnology Today November 21, 2024 By News Team

Flying solo, Grail will cut 30% of staff and narrow its R&D, commercial focus

Bio Space November 21, 2024 By News Team

Gone are the days of Galera: Biotech says goodbye to staffers and initiates wind-down

Bio Space November 21, 2024 By News Team

In The News

Economic Storm Clouds Hovering Over Trump and Global Leaders August 25, 2019 By News Team
UN: Possible to Eradicate Malaria, but Probably Not Soon August 24, 2019 By News Team
Climate Change Turns Arctic Into Strategic, Economic Hotspot August 23, 2019 By News Team

Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. biotech-today.com is a wholly-owned subsidiary of Maynard Communication Limited.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

After clearing out heart disease drug, Arrowhead maps out obesity development plans

Denali reports new method to get antisense oligonucleotides across blood-brain barrier

Medable launches Medable Studio, an all-in-one software solution

Scientists discover free-floating bacterial gene that challenges cardinal rules of biology

Flying solo, Grail will cut 30% of staff and narrow its R&D, commercial focus

Gone are the days of Galera: Biotech says goodbye to staffers and initiates wind-down

In The News

Biotechnology Today

After clearing out heart disease drug, Arrowhead maps out obesity development plans

Denali reports new method to get antisense oligonucleotides across blood-brain barrier

Medable launches Medable Studio, an all-in-one software solution

Scientists discover free-floating bacterial gene that challenges cardinal rules of biology

Kezar drops solid tumor drug that has yet to prove worth in phase 1

Markets

Weekly Market Review – November 16, 2024

Weekly Market Review – November 9, 2024

Weekly Market Review – November 2, 2024

Weekly Market Review – October 12, 2024

Weekly Market Review – September 28, 2024

Bio Space

Flying solo, Grail will cut 30% of staff and narrow its R&D, commercial focus

Gone are the days of Galera: Biotech says goodbye to staffers and initiates wind-down

Metagenomi axes ALS program after seeing Biogen and Ionis flounder

Global News

SpaceX Starlink wins permit to send internet to customers like you

Facebook video calls soar 1000% during Italy’s lockdown

WeWork board’s special committee is demanding that SoftBank follow through with investment